SCHEMBL25465308

SCHEMBL25465308

COC(=O)c1nn[nH]c1Oc1ccc(C)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.43
▸ POLB P06746 3/20 0.43
▸ ALPL P05186 3/20 0.43
▸ RAB9A P51151 3/20 0.43
▸ GAA P10253 1/20 0.43
▸ CYP2C9 P11712 1/20 0.43
▸ TDP1 Q9NUW8 2/20 0.42
▸ MMP13 P45452 2/20 0.40
▸ ALDH1A1 P00352 7/20 0.39
▸ KMT2A Q03164 5/20 0.39
▸ MEN1 O00255 3/20 0.39
▸ KDM4E B2RXH2 3/20 0.37
▸ PKM P14618 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ STAT3 P40763 1/20 0.37
▸ HIF1A Q16665 1/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ NPC1 O15118 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25464912 0.96 RAB9A (0.47) MAPTPOLBALPLRAB9AGAA
SCHEMBL23319888 0.87 SMN1; SMN2 (0.43) MAPTALPLRAB9ATDP1ALDH1A1
SCHEMBL25463661 0.87 MAPT (0.45) MAPTPOLBALPLGAAALDH1A1
SCHEMBL23319953 0.87 HAO1 (0.43) MAPTPOLBALPLRAB9AMMP13
SCHEMBL21312442 0.85 GAA (0.45) ALPLGAACYP2C9TDP1MMP13
SCHEMBL25463689 0.85 SMN1; SMN2 (0.46) MAPTALPLRAB9AGAAALDH1A1
SCHEMBL25464904 0.83 NPC1 (0.39) MAPTALPLRAB9ACYP2C9MMP13
SCHEMBL25465031 0.83 HAO1 (0.45) MAPTKMT2AMEN1HAO1
SCHEMBL25465122 0.82 MAPT (0.43) MAPTPOLBALPLRAB9AGAA
SCHEMBL21296970 0.81 ALPL (0.42) MAPTPOLBALPLRAB9AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230143491-A1 TRIAZOLE GLYCOLATE OXIDASE INHIBITORS PHOENIX TISSUE REPAIR, INC. 2023-05-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230143491-A1 TRIAZOLE GLYCOLATE OXIDASE INHIBITORS XDH, DUOX1, PNPO MAPT 1718/4885POLB 1757/4885ALPL 652/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback